State Of Alaska, Department Of Revenue Krystal Biotech, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 15,130 shares of KRYS stock, worth $2.27 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,130
Previous 14,024
7.89%
Holding current value
$2.27 Million
Previous $2.53 Million
17.76%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding KRYS
# of Institutions
332Shares Held
24.2MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$593 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$424 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$410 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$184 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$143 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.85B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...